BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22475593)

  • 1. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
    Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.
    Leang R; Canavati SE; Khim N; Vestergaard LS; Borghini Fuhrer I; Kim S; Denis MB; Heng P; Tol B; Huy R; Duparc S; Dondorp AM; Menard D; Ringwald P
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3884-90. PubMed ID: 26926629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
    Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
    Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
    Duparc S; Borghini-Fuhrer I; Craft CJ; Arbe-Barnes S; Miller RM; Shin CS; Fleckenstein L
    Malar J; 2013 Feb; 12():70. PubMed ID: 23433102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
    Poravuth Y; Socheat D; Rueangweerayut R; Uthaisin C; Pyae Phyo A; Valecha N; Rao BH; Tjitra E; Purnama A; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
    PLoS One; 2011 Jan; 6(1):e14501. PubMed ID: 21267072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Taylor M; Fox T; Hine P
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
    Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
    Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
    Kayentao K; Doumbo OK; Pénali LK; Offianan AT; Bhatt KM; Kimani J; Tshefu AK; Kokolomami JH; Ramharter M; de Salazar PM; Tiono AB; Ouédraogo A; Bustos MD; Quicho F; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
    Malar J; 2012 Oct; 11():364. PubMed ID: 23113947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
    Gargano N; Ubben D; Tommasini S; Bacchieri A; Corsi M; Bhattacharyya PC; Rao BH; Dubashi N; Dev V; Ghosh SK; Kumar A; Srivastava B; Valecha N
    Malar J; 2012 Jul; 11():233. PubMed ID: 22818552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated
    Leang R; Mairet-Khedim M; Chea H; Huy R; Khim N; Mey Bouth D; Dorina Bustos M; Ringwald P; Witkowski B
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
    Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
    Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    Tona Lutete G; Mombo-Ngoma G; Assi SB; Bigoga JD; Koukouikila-Koussounda F; Ntamabyaliro NY; Ntoumi F; Agnandji ST; Groger M; Shin J; Borghini-Fuhrer I; Arbe-Barnes S; Allen SJ; Kremsner PG; Miller R; Duparc S; Ramharter M;
    PLoS Med; 2021 Jun; 18(6):e1003669. PubMed ID: 34129601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.